אולנזאפין דקסל 5 מ"ג

Страна: Ізраїль

мова: іврит

Джерело: Ministry of Health

Активний інгредієнт:

OLANZAPINE 5 MG

Доступна з:

DEXCEL PHARMA TECHNOLOGIES LTD

Код атс:

N05AH03

Фармацевтична форма:

TABLETS

Адміністрація маршрут:

PER OS

Виробник:

DEXCEL LTD

Терапевтична група:

OLANZAPINE

Терапевтичні свідчення:

Acute and maintenance treatment of schizophrenia. Olanzapine is indicated for the management of the manifestations of psychotic disorders. Olanzapine is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. Prevention of recurrence in Bipolar Disorder: in patients whose manic episodes has responded to olanzapine treatment, olanzapine is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder: the combination of olanzapine with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.

Дата Авторизація:

2012-05-01